Latest Headlines

  1. Ignyta Announces Exploration Of Strategic Options For Taladegib, Enabled By Amendment Of Taladegib License Agreement With Lilly

    Ignyta, Inc., a biotechnology company focused on precision medicine in oncology, recently announced that it is exploring strategic options for taladegib and has entered into an amended and restated license, development and commercialization agreement with Eli Lilly and Company for the taladegib oncology program

  2. Open-Access Model Of Data-Sharing Enhances Cancer Research

    In a Sounding Board article published in the New England Journal of Medicine (NEJM) recently, Project Data Sphere, LLC (PDS) stakeholders call on organizations to share cancer clinical trial data with global researchers in a responsible way that will advance cancer research for patient benefit

  3. New CDISC Data Standard Aids Development Of Therapies For Ebola Virus

    The Clinical Data Interchange Standards Consortium (CDISC) and the Infectious Diseases Data Observatory (IDDO) announce the availability of a new standard to assist in the collection, aggregation and analysis of Ebola virus disease (EVD) research data

  4. The Chilling Incubator May Produce Untold Benefits For Life Science With WiFi Capable Incufridge

    The IoT (Internet of Things) is revolutionizing the way the world operates. Devices with internet and WiFi connectivity are making a huge impact on businesses and individual consumers alike

  5. Comparing Sensitivity & Efficiency Of N-ChIP-seq And X-ChIP-seq Kits

    Chromatrap has published a new article that describes a detailed genome wide comparison of native and crosslinked chromatin immunoprecipitation followed by next generation sequencing (ChIP-seq) using the company's patented solid state spin column technology

  6. Hamilton Robotics And Zymo Research Corporation Collaborate To Enable High Throughput Epigenetics Research

    Hamilton Robotics and Zymo Research Corporation announced an ongoing collaboration that unites Zymo Research’s epigenetics innovations with Hamilton’s high-throughput workflow expertise

  7. Automation-Friendly Kit For Capture Of Circulating Free DNA And Liquid Biospy

    AMSBIO has announced the launch of its new cfPure Cell Free DNA Purification Kit for scalable and automation-friendly isolation of circulating cell-free DNA (cfDNA) from patient serum or plasma samples

  8. European Group On Tumour Markers (EGTM) Updated Guidelines Recommend Agendia’s MammaPrint Test With Highest Level 1A Clinical Evidence

    Agendia, a world leader in personalized medicine and molecular cancer diagnostics, announces that updated guidelines from the European Group on Tumour Markers (EGTM), published recently online in the European Journal of Cancer (EJC), name the MammaPrint 70-Gene Breast Cancer Risk-of-Recurrence test as the first and currently the only multigene test of its kind deemed to have level 1A evidence for its clinical use

  9. Agilent Technologies Enhances Exome Sequencing For Clinical Research

    Agilent Technologies Inc. recently introduced a new target enrichment solution for next-generation DNA sequencing. Agilent SureSelect Clinical Research Exome V2 delivers more than 1,000 additional, disease relevant targets compared to the company’s earlier version of the product

  10. Here's Why You Should Purchase A Brand New Spirometer For Your Medical Practice

    The most popular pulmonary function test otherwise known as the “Spirogram” test requires data from both a volume-time curve and a flow-volume curve, which will require your spirometer to have a full flow volume loop and interpretation in order to properly conduct a pulmonary function or stress function test